US2013281666A1PendingUtilityA1

Methods of activating clostridial toxins

Assignee: ALLERGAN INCPriority: Jul 26, 2007Filed: Apr 30, 2013Published: Oct 24, 2013
Est. expiryJul 26, 2027(~1 yrs left)· nominal 20-yr term from priority
C07K 14/33C07K 2319/50C12P 21/02C12P 21/06
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The specification discloses modified Clostridial toxins comprising an exogenous Clostridial toxin di-chain loop protease cleavage site located within the di-chain loop region; polynucleotide molecules encoding such modified Clostridial toxins; method of producing such modified Clostridial toxins, method of activating such modified Clostridial toxins and methods of activating recombinantly-expressed Clostridial toxins.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . A modified Clostridial toxin comprising an exogenous BoNT/A di-chain loop region including a BoNT/A di-chain protease cleavage site;
 wherein the Clostridial toxin is a BoNT/B; and,   wherein the BoNT/A di-chain loop region replaces an endogenous Clostridial toxin di-chain loop region.   
     
     
         2 . A polynucleotide molecule encoding a modified Clostridial toxin according to  claim 1 . 
     
     
         3 . A method of producing a modified Clostridial toxin comprising the step of expressing in a cell a polynucleotide molecule according to  claim 2 , wherein expression from the polynucleotide molecule produces the encoded modified Clostridial toxin. 
     
     
         4 . A method of producing a modified Clostridial toxin comprising the steps of:
 a. oducing into a cell a polynucleotide molecule as defined in  claim 2 ; and   b. expressing the polynucleotide molecule, wherein expression from the polynucleotide molecule produces the encoded modified Clostridial toxin.

Join the waitlist — get patent alerts

Track US2013281666A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.